Mounjaro KwikPen

  • Prescription medication for weight management
  • Mimics natural hormone to control appetite
  • Best paired with diet and exercise
  • Administered via weekly injections


Mounjaro KwikPen: Revolutionizing Diabetes Management and Weight Control

What is Mounjaro KwikPen?

Mounjaro KwikPen, containing the active substance tirzepatide, is a leading-edge medical solution designed to manage blood sugar levels in adults with type 2 diabetes and aid in weight management. This easy-to-use pre-filled injection pen helps in regulating your appetite and reducing food cravings by promoting a feeling of fullness.

Indications and Usage

Mounjaro is not just a medication but a lifestyle change facilitator. It is prescribed for:

  • Type 2 diabetes management, especially when traditional medicines like metformin are not suitable.
  • Weight loss and maintenance in adults with a BMI of 27 kg/m² or higher, who also have weight-related health conditions.

Benefits of Mounjaro KwikPen

Mounjaro KwikPen simplifies diabetes management and weight control with numerous benefits:

  • Effective reduction of high blood sugar levels.
  • Supports substantial and sustained weight loss.
  • Enhances satiety and controls appetite, reducing the urge to overeat.

Dosage and Administration

Starting with a dose of 2.5 mg once a week, Mounjaro dosage can be adjusted based on therapeutic response but should only be modified under medical supervision. The pen allows for flexible administration, capable of being used at any time of the day, with or without meals.

Potential Side Effects

While Mounjaro KwikPen is a powerful tool for managing diabetes and weight, it can have side effects, which may include nausea, diarrhea, and hypoglycemia. Most side effects are manageable and tend to decrease over time.


Before using Mounjaro, discuss potential health risks with your healthcare provider. This medication should not be used if you are allergic to tirzepatide or during pregnancy. Monitoring for symptoms of pancreatitis is crucial due to severe possible complications.

Storage Instructions

Mounjaro KwikPen should be stored in a refrigerator, but it can be kept at room temperature under 30°C for up to 30 days. Do not freeze the pen, and discard it if the medication becomes cloudy or discolored.

How to Report Side Effects

Reporting side effects is essential for gathering more information about the safety of this medication. Side effects can be reported to your health provider or directly via the MHRA Yellow Card Scheme.


Mounjaro: How it works


Frequently asked question.

Is Mounjaro approved for weight loss?

Mounjaro (tirzepatide) is primarily approved for the wight loss due to its effectiveness in promoting significant weight loss, it is often discussed as a potential treatment for obesity and may soon seek approval specifically for weight loss.

Is Ozempic or Mounjaro better for weight loss?

Both Mounjaro and Ozempic have shown effectiveness in promoting weight loss, especially in patients with type 2 diabetes. Mounjaro, however, has shown promising results in clinical trials for producing more significant weight loss compared to other drugs, including semaglutide (the active ingredient in Ozempic and Wegovy).

How much does Mounjaro cost per month?

The cost of Mounjaro can vary, but in the U.K., it is approximately £150 per month without insurance. Prices in the UK and other regions may vary depending on healthcare policies and insurance coverage.

Can you take Mounjaro if you are not diabetic?

While Mounjaro is approved for use in patients with type 2 diabetes, it may be prescribed off-label for weight loss. However, its use in non-diabetics should be closely monitored by a healthcare professional due to potential side effects and the need for proper dosage.

Can I get Mounjaro on NHS?

As of now, Mounjaro is not routinely available on the NHS for weight loss or diabetes treatment. It may become available pending approval and review by NHS authorities.

What is the new weight loss drug in the UK?

The latest significant weight loss drug approved in the UK is Wegovy, which uses the active ingredient semaglutide, specifically approved for obesity management. It offers a new option for individuals struggling with weight issues, alongside a reduced-calorie diet and increased physical activity.

Is Mounjaro safe for weight loss?

Mounjaro has been found to be effective and generally safe in clinical trials for weight loss among diabetic patients. Ongoing studies are evaluating its safety and effectiveness specifically for weight loss in a broader population.

When will Wegovy be available in the UK?

Wegovy has been approved in the UK and is available for prescription for weight management under specific conditions, such as having a certain body mass index (BMI) and at least one weight-related health condition.